Home > Insider Trading > Filing (0001144204-19-028726)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
3116	Akorn Inc	AKRX	Pharmaceutical Preparations (2834)	720717400

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1124179	J Steven Meyer	C/O Akorn, Inc. 1925 W. Field Court, Suite 300 Lake Forest IL 60045		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-05-29	10,000	$3.75	163,154	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,210	Indirect	Spouse trust
Common Stock	1,250	Indirect	Child's trust
Common Stock	1,250	Indirect	Child's trust
Common Stock	1,250	Indirect	Child's trust
Common Stock	225	Indirect	Reporting Person trust

Footnotes

Represents the weighted average purchase price of the shares purchased. The shares were purchased at prices ranging from $3.73 to $3.75. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at separate prices within the foregoing range.
Following the reported transaction, the amount of shares beneficially owned includes 46,610 unvested Restricted Stock Units (RSUs) and 116,544 shares owned outright.
The Reporting Person is a trustee of this family trust.
This trust is held for the benefit of a child of the Reporting Person.